NCT06998797View on ClinicalTrials.gov

Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Ulcerative Colitis
Interventions
OTHER

Data collection

Data collection from medical records

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06998797 - Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study | Biotech Hunter | Biotech Hunter